Peripheral Artery Tonometry in Children With Type 1 Diabetes and Obese Children
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Dec 27, 2010
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new, painless method called reactive hyperemia-peripheral artery tonometry (RH-PAT) to check how well blood vessels are functioning in children and teenagers. The researchers want to find out if there are differences in RH-PAT scores between adolescents with type 1 diabetes and those without, as well as between obese adolescents and their healthier peers. Understanding these differences could help doctors better care for young patients with diabetes and obesity.
To be eligible for this study, participants should be between 12 and 19 years old and should not have type 2 diabetes or obesity if they have type 1 diabetes. The trial is currently looking for volunteers, and all genders are welcome to join. Participants can expect to undergo a simple, noninvasive test that does not require any needles, making it a comfortable experience. This research could provide valuable insights that may improve future treatments and health management for children facing these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 12-19 years of age
- Exclusion Criteria:
- • type 2 diabetes; obesity in group of type 1 diabetes
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials